The report on the Global Gene Therapy Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of comprehensive research. The report gives a complete market analysis for the forecasted period from 2019 to 2026. The market is portioned into various segments with an in-depth outlook of the competitive outlook and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
Gene therapy includes use of DNA as a pharmaceutical agent to treat diseases. It promises to be one of the most important frontiers in medicine and a promising treatment option for a number of diseases (including inherited disorders, some types of cancer, and certain viral infections). In the recent scenario, various pharmaceutical companies are using clinical data to validate the concept of gene therapy. Moreover, many venture capital investors are also showing their interest in gene therapy, and are investing heavily in its development.
Gene therapy market is segmented by types, technology, applications, vectors and geography. On the basis of types the market is segmented into somatic gene therapy and germline gene therapy. On the basis of technology the market is further segmented by type of gene therapy, physical methods and chemical methods. On the basis of type of gene therapy the market is further segmented into ex vivo gene therapy and in vivo gene therapy. On the basis of physical methods the market is segmented into electroporation, microinjection, particle bombardment, ultrasound-mediated transfection, molecular vibration, laser irradiation, photochemical transfection. On the basis of chemical methods the market is further segmented into gene repair and replacement, gene editing by using short synthetic oligonucleotides, genome engineering by using TALENs, genome engineering by using CRISPR system, mRNA gene therapy, spliceosome mediated RNA trans-splicing. On the basis of application the market is segmented into oncology, infectious diseases, genetic disorders, cardiovascular disorders, diabetes mellitus, hypertension and neurological disorder. Based on geography the market is segmented into the North America, Europe, Asia and Rest of the World (RoW).
The growth is attributed to development in the gene silencing technology, increasing demand for gene therapy in immunodeficiency syndromes, growing popularity of DNA vaccines, and development in the nanotechnology. However, stringent regulatory laws in U.S. and Europe for gene therapy, side effects of gene therapy, Occurrence of Multigene Disorders in Gene Therapy and technical limitations are hindering the growth of this market.
The key players in this market are:
TABLE OF CONTENTS
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Gene Therapy Market
2.2. Global Gene Therapy Market Snapshot
3 . GENE THERAPY – INDUSTRY ANALYSIS
3.1. Introduction
3.2. Market Drivers of Gene Therapy Market
3.3. Market Restraints of Gene Therapy Market
3.4. Opportunities of Gene Therapy Market
3.5. Trends of Gene Therapy Market
3.6. Porter’s Five Force Analysis of Gene Therapy Market
3.7. Gene Therapy Market Attractiveness Analysis
3.7.1 Market Attractive Analysis by Type
3.7.2 Market Attractive Analysis by Application
3.7.3 Market Attractive Analysis by Technology
3.7.4 Market Attractive Analysis by Type of Vectors
3.7.5 Market Attractive Analysis by Region
4 . VALUE CHAIN ANALYSIS
4.1. Gene Therapy Value Chain Analysis
4.2. Gene Therapy Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Gene Therapy Raw Material Manufactures List
4.2.3. Price Trend of Gene Therapy Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL GENE THERAPY MARKET ANALYSIS BY TYPE
5.1 Overview by Type
5.2 Global Gene Therapy Market Analysis by Type
5.3 Market Analysis of Somatic Gene therapy by Regions
5.4 Market Analysis of Germline Gene therapy by Regions
6 . GLOBAL GENE THERAPY MARKET ANALYSIS BY APPLICATION
6.1 Overview by Application
6.2 Global Gene Therapy Market Analysis by Application
6.3 Market Analysis of Genetic Disorders by Regions
6.4 Market Analysis of Neurological Disorder by Regions
6.5 Market Analysis of Oncology by Regions
6.6 Market Analysis of Cardiovascular Disorders by Regions
6.7 Market Analysis of Diabetes Mellitus by Regions
6.8 Market Analysis of Infectious Diseases by Regions
6.9 Market Analysis of Hypertension by Regions
7 . GLOBAL GENE THERAPY MARKET ANALYSIS BY TECHNOLOGY
7.1 Overview by Technology
7.2 Global Gene Therapy Market Analysis by Technology
7.3 Market Analysis of Ex vivo and in vivo gene therapy by Regions
7.4 Market Analysis of Physical methods by Regions
7.5 Market Analysis of Chemical methods by Regions
8 . GLOBAL GENE THERAPY MARKET ANALYSIS BY TYPE OF VECTORS
8.1 Overview by Type of Vectors
8.2 Global Gene Therapy Market Analysis by Type of Vectors
8.3 Market Analysis of Viral vectors by Regions
8.4 Market Analysis of Retroviral vectors by Regions
8.5 Market Analysis of Nonviral vectors by Regions
8.6 Market Analysis of Artificial viral vectors by Regions
9 . GLOBAL GENE THERAPY MARKET ANALYSIS BY GEOGRAPHY
9.1. Regional Outlook
9.2. Introduction
9.3. North America
9.3.1. Overview
9.3.2. North America Gene Therapy Market Estimate by Country
9.3.3. United State
9.3.4. Rest of North America
9.4. Europe
9.4.1. Overview
9.4.2. Europe Gene Therapy Market Estimate by Market Segment
9.4.3. Europe Gene Therapy Market Estimate by Country
9.4.4. United Kingdom
9.4.5. France
9.4.6. Germany
9.4.7 Rest of Europe
9.5. Asia Pacific
9.5.1. Overview
9.5.2. Asia Pacific Gene Therapy Market Estimate by Market Segment
9.5.3. Asia Pacific Gene Therapy Market Estimate by Country
9.5.4. China
9.5.5. Japan
9.5.6. India
9.5.7. Rest of Asia Pacific
9.6. Latin America
9.6.1. Overview
9.6.2. Latin America Gene Therapy Market Estimate by Market Segment
9.6.3. Latin America Gene Therapy Market Estimate by Country
9.6.4. Brazil
9.6.5. Rest of Latin America
9.7. Middle East & Africa
9.7.1. Overview
9.7.2. Middle East & Africa Gene Therapy Market Estimate by Market Segment
9.7.3. Middle East & Africa Gene Therapy Market Estimate by Country
9.7.4. Middle East
9.7.5. Africa
10 COMPETITIVE LANDSCAPE OF THE GENE THERAPY COMPANIES
10.1. Gene Therapy Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments
11 COMPANY PROFILES OF GENE THERAPY INDUSTRY
11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. AnGes MG, Inc
11.3.1. Company Overview
11.3.2. Financials
11.3.3. Products
11.3.4. Recent Developments
11.4. Ark Therapeutics
11.4.1. Company Overview
11.4.2. Financials
11.4.3. Products
11.4.4. Recent Developments
11.5. Ceregene, Inc
11.5.1. Company Overview
11.5.2. Financials
11.5.3. Products
11.5.4. Recent Developments
11.6. Cobra Biologics
11.6.1. Company Overview
11.6.2. Financials
11.6.3. Products
11.6.4. Recent Developments
11.7. GenVec, Inc
11.7.1. Company Overview
11.7.2. Financials
11.7.3. Products
11.7.4. Recent Developments
11.8. Genzyme Corporation
11.8.1. Company Overview
11.8.2. Financials
11.8.3. Products
11.8.4. Recent Developments
11.9. Vical, Inc
11.9.1. Company Overview
11.9.2. Financials
11.9.3. Products
11.9.4. Recent Developments
11.10. Oxford BioMedica
11.10.1. Company Overview
11.10.2. Financials
11.10.3. Products
11.10.4. Recent Developments
11.11. BioSante Pharmaceuticals
11.11.1. Company Overview
11.11.2. Financials
11.11.3. Products
11.11.4. Recent Developments
11.12. Shenzhen SiBiono GeneTech Co., Ltd
11.12.1. Company Overview
11.12.2. Financials
11.12.3. Products
11.12.4. Recent Developments
11.13. Transgene
11.13.1. Company Overview
11.13.2. Financials
11.13.3. Products
11.13.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
The report on the Global Tigecycline Market gives an estimation of the development of the market based on historical studies and also provides forecasts read more..
The Global Risperidone Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks read more..
Opioids Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast read more..
The report on the Global Caffeine Market gives an estimation of the development of the market based on historical studies and also provides forecasts on read more..
The report on the Global Rabies Vaccine Market gives an estimation of the development of the market based on historical studies and also provides read more..
The report on the Global Radiopharmaceuticals Market gives an estimation of the development of the market based on historical studies and also provides read more..
The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also read more..
The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and read more..
The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and read more..
The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013. A number of factors such as increasing bone related read more..